Aurora Cannabis (ACB) Non Operating Income (2017 - 2026)

Aurora Cannabis (ACB) posted quarterly Non Operating Income of -$34272.7 for Q1 2026, up 99.67% year-on-year from -$17164.4 in Q1 2025, and up 93.2% on a QoQ basis from -$504111.7 in Q4 2025.

Aurora Cannabis (ACB) Non Operating Income (2017 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Non Operating Income for 10 consecutive years, with -$34272.7 the latest figure, recorded in Q1 2026.

  • Quarterly Non Operating Income rose 99.67% year-over-year to -$34272.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.4 million (up 59.81% YoY) and the FY2026 annual result came in at $520998.9, up 103.38% from the prior year.
  • Non Operating Income grew to -$34272.7 in Q1 2026 per ACB's latest filing, from -$504111.7 in the prior quarter.
  • Over the last five years, Non Operating Income for ACB reached as high as $742.1 million in Q1 2022 and fell as low as -$11.7 million in Q2 2022.
  • A 5-year average of $48.9 million and a median of -$1.3 million in 2025 frame the typical range for Non Operating Income.
  • Annual changes were most pronounced in 2022 — Non Operating Income surged 5628.28% — and 2025, when it slumped 156.04%.
  • Year by year, Non Operating Income stood at $5.7 million in 2022, then slumped by 103.48% to -$199000.0 in 2023, then soared by 2522.61% to $4.8 million in 2024, then sank by 110.46% to -$504111.7 in 2025, then soared by 93.2% to -$34272.7 in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods registered -$34272.7, -$504111.7, and -$1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -216.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 20.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -7.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 53.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn -34,272.67

Historic Data

Download Data
DateValue
Mar 31, 2026 -34,272.67
Dec 31, 2025 -504,111.66
Sep 30, 2025 -1.61 Mn
Jun 30, 2025 -1.28 Mn
Mar 31, 2025 -10.49 Mn
Dec 31, 2024 4.82 Mn
Sep 30, 2024 -1.59 Mn
Jun 30, 2024 -1.29 Mn
Mar 31, 2024 18.72 Mn
Dec 31, 2023 -199,000.00
Sep 30, 2023 -3.06 Mn
Dec 31, 2022 5.73 Mn
Sep 30, 2022 -6.28 Mn
Jun 30, 2022 -11.71 Mn
Mar 31, 2022 742.10 Mn
Dec 31, 2021 -12.62 Mn
Sep 30, 2021 34.28 Mn
Jun 30, 2021 -298.10 Mn
Mar 31, 2021 -13.42 Mn
Dec 31, 2020 -14.48 Mn